'Curse' which killed explorers entering Egyptian tombs could fight cancer
The "Pharaoh's Curse" which killed archaeologists, scientists and explorers who broke into the tombs of ancient kings in Egypt has been transformed into an anti-cancer drug. After archaeologists opened King Tutankhamun's tomb in the 1920s, a series of untimely deaths among the excavation team fuelled rumours of a "pharaoh's curse".
A dozen scientists entered the tomb of Casimir IV in Poland In the 1970s but, within weeks, 10 of them died. Decades later, doctors theorised that fungal spores, dormant for millennia, could have played a role.
Scientists isolated a new class of molecules from Aspergillus flavus, a toxic crop fungus linked to infamous deaths following the excavations of ancient tombs. Later investigations revealed the tomb contained A. flavus, whose toxins can lead to lung infections, especially in people with compromised immune systems.
Now, that same fungus is the unlikely source of a promising new cancer therapy. American scientists modified the chemicals they isolated from A. flavus and tested them against leukaemia cells.
Their findings, published in the journal Nature Chemical Biology, showed a "promising" cancer-killing compound that rivals already-approved drugs - and opens new frontiers for fungal medicines. Study senior author Professor Sherry Gao, of the University of Pennsylvania, said: 'Fungi gave us penicillin.
'These results show that many more medicines derived from natural products remain to be found.' She explained that the therapy in question is a class of ribosomally synthesised and post-translationally modified peptides, or RiPPs.
The name refers to how the compound is produced - by the ribosome, a tiny cellular structure that makes proteins - and the fact that it is modified later to enhance its cancer-killing properties. Study first author Dr Qiuyue Nie said: 'Purifying these chemicals is difficult."
She says that while thousands of RiPPs have been identified in bacteria, only a handful have been found in fungi. Dr Nie said that is because researchers previously misidentified fungal RiPPs as non-ribosomal peptides and had little understanding of how fungi created the molecules.
She added: 'The synthesis of these compounds is complicated. But that's also what gives them this remarkable bioactivity.'
To find more fungal RiPPs, the research team first scanned a dozen strains of Aspergillus, which previous research suggested might contain more of the chemicals. By comparing chemicals produced by these strains with known RiPP building blocks, the researchers identified A. flavus as a "promising" candidate for further study.
Genetic analysis pointed to a particular protein in A. flavus as a source of fungal RiPPs. When the researchers turned the genes that create that protein off, the chemical markers indicating the presence of RiPPs also disappeared.
They said the new approach - combining metabolic and genetic information - not only pinpointed the source of fungal RiPPs in A. flavus, but could also be used to find more fungal RiPPs in the future. Further experiments suggested that asperigimycins likely disrupt the process of cell division. Prof Gao said: 'Cancer cells divide uncontrollably. These compounds block the formation of microtubules, which are essential for cell division.'
She says the compounds had little to no effect on breast, liver or lung cancer cells - or a range of bacteria and fungi - suggesting that asperigimycins' disruptive effects are specific to certain types of cells, a critical feature for any future medication. As well as showing the medical potential of asperigimycins, the research team also identified similar clusters of genes in other fungi, suggesting that more fungal RiPPS remain to be discovered.
Dr Nie said: 'Even though only a few have been found, almost all of them have strong bioactivity. This is an unexplored region with tremendous potential.'
The researchers say the next step is to test asperigimycins in animal models, with the hope of one day moving to human clinical trials. Prof Gao added: 'Nature has given us this incredible pharmacy. It's up to us to uncover its secrets. As engineers, we're excited to keep exploring, learning from nature and using that knowledge to design better solutions.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economist
6 days ago
- Economist
Quantifying Trumpcare
JUST READING the Big Beautiful Bill, with its 330 pages of provisions, is an intimidating undertaking. Working out its consequences is yet more challenging. Nevertheless, researchers at the University of Pennsylvania and the Yale School of Public Health tried to calculate how many more people would die as a result of the law. Analysing the House of Representatives' version of the bill, they came to 42,500 annually by 2034. That is more people than currently die of breast cancer. Adding in the impact of the end of the enhanced subsidies for people buying their own insurance, they reckoned there would be over 51,000 extra deaths a year. The White House has pushed back on the claims of deaths, calling them 'egregious' and 'deranged'.
Daily Mail
07-07-2025
- Daily Mail
Chilling discovery exposes tiny differences between psychopaths and ordinary people
Scientists have discovered what really separates a cold-blooded psychopath from the average person. A team from the University of Pennsylvania has uncovered stark differences in brain structure that may explain why psychopaths think, feel, and behave in profoundly disturbing ways. Using MRI scans, researchers compared the brains of 39 adult men with high psychopathy scores to those of a control group, and what they found was unsettling. In psychopaths, researchers found shrunken areas in the basal ganglia, which controls movement and learning, the thalamus, the body's sensory relay station, and the cerebellum, which helps coordinate motor function. But the most striking changes were found in the orbitofrontal cortex and insular regions, areas that govern emotional regulation, impulse control, and social behavior. In other words, the parts of the brain that keep most people from lying, lashing out or harming others were noticeably compromised. 'These are the very traits psychopaths struggle with,' the researchers explained. However, the scan also revealed weaker connections between brain regions tied to empathy, guilt, and moral reasoning, suggesting that the callous behavior of psychopaths may not just be a personality issue, but is deeply rooted in neural wiring. While some traits, like deception and manipulation, are likely shaped by life experience, the physical brain differences point to a biological foundation for why psychopaths act the way they do. And that, scientists say, could help unlock new ways to identify, and possibly treat, individuals at risk of extreme antisocial behavior. The research, published in European Archives of Psychiatry and Clinical Neuroscience, found noticeable impairments in the amygdala. This powerful region helps control fear, anger, and emotional recognition, the foundation for behaving like a socially functioning human being. When it's not working properly, the result isn't just mood swings, it's a total breakdown in how a person reads others and regulates their behavior. That disconnect can show up in chilling ways: Psychopaths often can't display emotions through facial expressions, making them appear cold, detached, or unnervingly shallow. Impulsive behaviors stem from the neurological abnormalities found in the study, which explained why less than one percent of the global population are psychopaths, but 20 percent of people in prison display psychopathic tendencies. According to the research, most people don't commit violent crimes, but 60 percent lie in casual conversation, 40 to 60 percent ignore traffic speed limits, and 10 percent have used illicit drugs. Past studies have even suggested that psychopaths may have a malfunctioning mirror neuron system, the part of the brain that helps us mimic and learn behavior by observing others. In other words, where most people would instinctively learn empathy by watching someone cry or suffer, a psychopath might feel nothing. Experts often avoid using the label outright, fearing the stigma it carries. Instead, psychologists use a detailed diagnostic tool known as the Psychopathy Checklist to assess traits and assign a score. Many diagnosed psychopaths don't end up in prison or treatment. They blend in. They learn how to mimic normal emotions, mask dangerous impulses, and move through society unnoticed. A study published in March found a disturbing sign that individuals may be psychopaths. Scientists have found a link between psychopathy and 'sadism' – deriving pleasure from inflicting pain, suffering or humiliation on others. Examples of sadism include trolling people online, killing video game characters, killing bugs and even sticking pins on voodoo dolls. So if you engage in these sadistic behaviours – even if it's just making other people feel embarrassed online – you could be a psychopath. The experts, from Maastricht University in the Netherlands, warn that sadism might be more common than previously thought. In disturbing experiments, they found members of the public were more than willing to startle people and inflict harm on bugs. 'Sadistic pleasure, gratuitous enjoyment from inflicting pain on others, has devastating interpersonal and societal consequences,' the experts report. '[Our study] is the first to assess state sadism directed at both humans and animals.'
The Sun
24-06-2025
- The Sun
How ‘Pharaoh's curse' may help fight CANCER after leukaemia-battling chemical found in fungus linked to King Tut deaths
A TOXIC fungus linked to the deaths of researchers who opened King Tutankhamun's tomb may help fight cancer. The poisonous fungus found growing inside the ancient tombs is believed to have struck down a team of 10 archaeologists in a theory known as " Pharaoh's Curse". 3 3 The fungus crop - known as Aspergillus flavus - is believed to have been ingested by the researchers who then developed lung infections and died. But now, in a miraculous turn of events, scientists think the toxic fungus could contain elements needed to attack blood cancer. The fungus contains a "promising" protein that, when purified, could help battle leukaemia cells, they said. According to their research, when combined with human cells, the protein is potent enough to disrupt the division of cancer cells. Cancer is when abnormal cells divide in an uncontrolled way. It starts when gene changes make one cell or a few cells begin to grow and multiply too much. Sherry Gao, a professor at the University of Pennsylvania, enthused that this could be the start of "many more medicines derived from natural products". She told The Times: "Fungi gave us penicillin. These results show that many more medicines derived from natural products remain to be found". She added: "Nature has given us this incredible pharmacy. It's up to us to uncover its secrets. "As engineers, we're excited to keep exploring, learning from nature and using that knowledge to design better solutions.' Tourists gather around Tutankhamun's 'cursed' body This comes as researchers at Case Western Reserve University and Cleveland Clinic, both in the US, developed a new type of jab to fight pancreatic cancer. The vaccine uses tiny particles called nanoparticles to train the body's immune system to find and kill 'bad' cancer cells. In early tests with animals and lab models of pancreatic ductal adenocarcinoma (PDAC), the most common and aggressive type of pancreatic cancer, more than half of the treated patients were completely cancer-free months after getting the vaccine. The vaccine also encourages the body to create its own T cells, immune fighters specially trained to attack cancer, while building up 'immune memory' for longer-term protection. Meanwhile, researchers in South Korea said they were able to revert cancerous cells back to a healthier stage. The team believe they can prevent the progression by exploiting the moment before normal cells irreversibly transform into diseased cells. Current cancer treatments focus on removing or destroying cancer cells through surgery, radiation or chemotherapy. But the groundbreaking discovery could let cancer patients regain their healthy cells. The scientists published their findings in the journal Advanced Science. Co-author of the new research Kwang-Hyun Cho is a professor of biology at the Korea Advanced Institute of Science and Technology. He said: "This study has revealed in detail, at the genetic network level, what changes occur within cells behind the process of cancer development, which has been considered a mystery until now.
